PATENT CLAIM ANALYSIS

Application Number: 16209600
Application Type: Utility
Filing Date: 2018-12
Publication Date: 2019-04
Patent Classification: ["424", "001210"]

Abstract:
The present invention relates to compounds and their uses, in particular, compounds in the form of prodrugs that promote transport of a pharmaceutical agent to the lymphatic system and subsequently enhance release of the parent drug.

Claim (Index 52):
The method according to  claim 50 , wherein the compound is administered orally with food to promote transport to the intestinal lymph, or is co-administered orally with a lipid based formulation to promote transport to the intestinal lymph.

Metadata:
- Claim Count in Document: 86.0
- Percentile: 98.0
- Lexical Diversity: 1.3
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15113986', '14965549', '12364310', '15750471', '11329267']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7419031728971163
- 35 USC 102 Novelty (BERT): 0.5292683620869169
- Combined Prediction Score: 0.7206396918160963
- Mean Citation Score: 279.354174
- Max Citation Score: 284.09033
- Similarity Product: 144.848880496068

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test